2015 Videocast Recordings
Introduction to the MCI Symposium 2015
Keynote Lecture: Assessing the Current Roadmap for Developing Novel Disease Modifying Therapies for Neurodegenerative Diseases
Neurodegenerative Tauopathies – Clinicopathologic Correlations
Role of TDP-43 in Non-Alzheimer’s and Alzheimer’s Neurodegenerative Diseases
Emerging Concepts in Chronic Traumatic Encephalopathy
New Approaches towards Interventions in Frontotemporal Dementia
How to Diagnose Early (Prodromal) Lewy Body Dementia
Discussion
Brain Networks in Neurodegenerative Disease
MCI of the FTLD type: Clinical Features and Imaging and Molecular Biomarkers
Imaging Characteristics of Prodromal Familial FTLD
Clinical and Imaging Features of Prodromal PPA
What is the Etiology of Amyloid Negative Mild Cognitive Impairment?
Moderator: Kimiko Domoto-Reilly, MD
WORKSHOP KEYNOTE LECTURE: Longitudinal Changes in Autosomal Dominant AD: Implications for Treatment
Correlating Cognition and Biomarkers in Preclinical APOE e4 and PS1 Mutation Carriers
Cross-sectional and Longitudinal Imaging studies in Non-demented Subjects: Mayo Clinic Study of Aging
Understanding Biomarker Relationships in Alzheimer’s Disease: The ADNI Experience
Cross-sectional and Longitudinal Studies in LOAD: AIBL Experience
T807 Tau PET in Aging and Dementia
Moderator: Reisa A. Sperling, MD, MMSc
Public Educational Forum: Welcome Notes
Factors which Modify Longevity in MCI and Dementia – the Mayo Clinic Experience
Personality, Lifestyle, and Cognitive Health in Old Age
Cognitive Engagement and Risk for MCI and Dementia
Risk Factors for Dementia in the Oldest Old
How Does Exercise Benefit People at Risk for Dementia?
Vascular Factors which Modify Risk for Dementia
Moderator: Steven T. DeKosky, MD